Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease

Clinical trial NCT01058018 · COMPLETED

Trial details

NCT number: NCT01058018
Sponsor: Resverlogix Corp
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atherosclerosis Coronary Artery Disease

Start date: 2009-12-01
Primary completion: 2010-06-01
Enrollment: 299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.